A Fresh Look at NASH Pathogenesis. Part 1: The Metabolic Movers

Claire Larter, Shiv Chitturi, Deborah HEYDET, Geoffrey C. Farrell

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

The strong relationship between over‐nutrition, central obesity, insulin resistance/metabolic syndrome and non‐alcoholic fatty liver disease (NAFLD) suggest pathogenic interactions, but key questions remain. NAFLD starts with over‐nutrition, imbalance between energy input and output for which the roles of genetic predisposition and environmental factors (diet, physical activity) are being redefined. Regulation of energy balance operates at both central nervous system and peripheral sites, including adipose and liver. For example, the endocannabinoid system could potentially be modulated to provide effective pharmacotherapy of NAFLD. The more profound the metabolic abnormalities complicating over‐nutrition (glucose intolerance, hypoadiponectinemia, metabolic syndrome), the more likely is NAFLD to take on its progressive guise of non‐alcoholic steatohepatitis (NASH). Interactions between steatosis and insulin resistance, visceral adipose expansion and subcutaneous adipose failure (with insulin resistance, inflammation and hypoadiponectinemia) trigger amplifying mechanisms for liver disease. Thus, transition from simple steatosis to NASH could be explained by unmitigated hepatic lipid partitioning with failure of local adaptive mechanisms leading to lipotoxicity. In part one of this review, we discuss newer concepts of appetite and metabolic regulation, bodily lipid distribution, hepatic lipid turnover, insulin resistance and adipose failure affecting adiponectin secretion. We review evidence that NASH only occurs when over‐nutrition is complicated by insulin resistance and a highly disordered metabolic milieu, the same ‘metabolic movers’ that promote type 2 diabetes and atheromatous cardiovascular disease. The net effect is accumulation of lipid molecules in the liver. Which lipids and how they cause injury, inflammation and fibrosis will be discussed in part two.
Original languageEnglish
Pages (from-to)672-690
Number of pages19
JournalJournal of Hepatology and Gastroenterology
Volume25
Issue number4
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Overnutrition
Insulin Resistance
Lipids
Liver
Inflammation
Appetite Regulation
Endocannabinoids
Glucose Intolerance
Abdominal Obesity
Adiponectin
Genetic Predisposition to Disease
Non-alcoholic Fatty Liver Disease
Type 2 Diabetes Mellitus
Liver Diseases
Fibrosis
Cardiovascular Diseases
Central Nervous System
Diet
Drug Therapy
Wounds and Injuries

Cite this

Larter, Claire ; Chitturi, Shiv ; HEYDET, Deborah ; Farrell, Geoffrey C. / A Fresh Look at NASH Pathogenesis. Part 1: The Metabolic Movers. In: Journal of Hepatology and Gastroenterology. 2010 ; Vol. 25, No. 4. pp. 672-690.
@article{c8efcc010b1e454682fe87e54ce10f7a,
title = "A Fresh Look at NASH Pathogenesis. Part 1: The Metabolic Movers",
abstract = "The strong relationship between over‐nutrition, central obesity, insulin resistance/metabolic syndrome and non‐alcoholic fatty liver disease (NAFLD) suggest pathogenic interactions, but key questions remain. NAFLD starts with over‐nutrition, imbalance between energy input and output for which the roles of genetic predisposition and environmental factors (diet, physical activity) are being redefined. Regulation of energy balance operates at both central nervous system and peripheral sites, including adipose and liver. For example, the endocannabinoid system could potentially be modulated to provide effective pharmacotherapy of NAFLD. The more profound the metabolic abnormalities complicating over‐nutrition (glucose intolerance, hypoadiponectinemia, metabolic syndrome), the more likely is NAFLD to take on its progressive guise of non‐alcoholic steatohepatitis (NASH). Interactions between steatosis and insulin resistance, visceral adipose expansion and subcutaneous adipose failure (with insulin resistance, inflammation and hypoadiponectinemia) trigger amplifying mechanisms for liver disease. Thus, transition from simple steatosis to NASH could be explained by unmitigated hepatic lipid partitioning with failure of local adaptive mechanisms leading to lipotoxicity. In part one of this review, we discuss newer concepts of appetite and metabolic regulation, bodily lipid distribution, hepatic lipid turnover, insulin resistance and adipose failure affecting adiponectin secretion. We review evidence that NASH only occurs when over‐nutrition is complicated by insulin resistance and a highly disordered metabolic milieu, the same ‘metabolic movers’ that promote type 2 diabetes and atheromatous cardiovascular disease. The net effect is accumulation of lipid molecules in the liver. Which lipids and how they cause injury, inflammation and fibrosis will be discussed in part two.",
keywords = "Adipose failure, Appetite",
author = "Claire Larter and Shiv Chitturi and Deborah HEYDET and Farrell, {Geoffrey C.}",
year = "2010",
doi = "10.1111/j.1440-1746.2010.06253.x",
language = "English",
volume = "25",
pages = "672--690",
journal = "Journal of Hepatology and Gastroenterology",
issn = "0270-9139",
publisher = "John Wiley & Sons",
number = "4",

}

A Fresh Look at NASH Pathogenesis. Part 1: The Metabolic Movers. / Larter, Claire; Chitturi, Shiv; HEYDET, Deborah; Farrell, Geoffrey C.

In: Journal of Hepatology and Gastroenterology, Vol. 25, No. 4, 2010, p. 672-690.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Fresh Look at NASH Pathogenesis. Part 1: The Metabolic Movers

AU - Larter, Claire

AU - Chitturi, Shiv

AU - HEYDET, Deborah

AU - Farrell, Geoffrey C.

PY - 2010

Y1 - 2010

N2 - The strong relationship between over‐nutrition, central obesity, insulin resistance/metabolic syndrome and non‐alcoholic fatty liver disease (NAFLD) suggest pathogenic interactions, but key questions remain. NAFLD starts with over‐nutrition, imbalance between energy input and output for which the roles of genetic predisposition and environmental factors (diet, physical activity) are being redefined. Regulation of energy balance operates at both central nervous system and peripheral sites, including adipose and liver. For example, the endocannabinoid system could potentially be modulated to provide effective pharmacotherapy of NAFLD. The more profound the metabolic abnormalities complicating over‐nutrition (glucose intolerance, hypoadiponectinemia, metabolic syndrome), the more likely is NAFLD to take on its progressive guise of non‐alcoholic steatohepatitis (NASH). Interactions between steatosis and insulin resistance, visceral adipose expansion and subcutaneous adipose failure (with insulin resistance, inflammation and hypoadiponectinemia) trigger amplifying mechanisms for liver disease. Thus, transition from simple steatosis to NASH could be explained by unmitigated hepatic lipid partitioning with failure of local adaptive mechanisms leading to lipotoxicity. In part one of this review, we discuss newer concepts of appetite and metabolic regulation, bodily lipid distribution, hepatic lipid turnover, insulin resistance and adipose failure affecting adiponectin secretion. We review evidence that NASH only occurs when over‐nutrition is complicated by insulin resistance and a highly disordered metabolic milieu, the same ‘metabolic movers’ that promote type 2 diabetes and atheromatous cardiovascular disease. The net effect is accumulation of lipid molecules in the liver. Which lipids and how they cause injury, inflammation and fibrosis will be discussed in part two.

AB - The strong relationship between over‐nutrition, central obesity, insulin resistance/metabolic syndrome and non‐alcoholic fatty liver disease (NAFLD) suggest pathogenic interactions, but key questions remain. NAFLD starts with over‐nutrition, imbalance between energy input and output for which the roles of genetic predisposition and environmental factors (diet, physical activity) are being redefined. Regulation of energy balance operates at both central nervous system and peripheral sites, including adipose and liver. For example, the endocannabinoid system could potentially be modulated to provide effective pharmacotherapy of NAFLD. The more profound the metabolic abnormalities complicating over‐nutrition (glucose intolerance, hypoadiponectinemia, metabolic syndrome), the more likely is NAFLD to take on its progressive guise of non‐alcoholic steatohepatitis (NASH). Interactions between steatosis and insulin resistance, visceral adipose expansion and subcutaneous adipose failure (with insulin resistance, inflammation and hypoadiponectinemia) trigger amplifying mechanisms for liver disease. Thus, transition from simple steatosis to NASH could be explained by unmitigated hepatic lipid partitioning with failure of local adaptive mechanisms leading to lipotoxicity. In part one of this review, we discuss newer concepts of appetite and metabolic regulation, bodily lipid distribution, hepatic lipid turnover, insulin resistance and adipose failure affecting adiponectin secretion. We review evidence that NASH only occurs when over‐nutrition is complicated by insulin resistance and a highly disordered metabolic milieu, the same ‘metabolic movers’ that promote type 2 diabetes and atheromatous cardiovascular disease. The net effect is accumulation of lipid molecules in the liver. Which lipids and how they cause injury, inflammation and fibrosis will be discussed in part two.

KW - Adipose failure

KW - Appetite

U2 - 10.1111/j.1440-1746.2010.06253.x

DO - 10.1111/j.1440-1746.2010.06253.x

M3 - Article

VL - 25

SP - 672

EP - 690

JO - Journal of Hepatology and Gastroenterology

JF - Journal of Hepatology and Gastroenterology

SN - 0270-9139

IS - 4

ER -